Literature DB >> 27080195

Association of intracellular Staphylococcus aureus with prognosis in chronic rhinosinusitis.

Judy Ou1, Amanda Drilling1, Deepti Singhal1, Neil C-W Tan1, Deanna Wallis-Hill2, Sarah Vreugde1, Alkis J Psaltis1, Peter-John Wormald1.   

Abstract

BACKGROUND: Staphylococcus aureus (S. aureus) has been shown to exist within nasal epithelial cells in chronic rhinosinusitis (CRS) patients. This study investigates the localization of intracellular S. aureus (ICSA) in CRS patients, the associated histopathology changes, and their effect on long-term postoperative outcomes.
METHODS: A prospective study of patients with CRS with and without polyps and control patients (n = 25, 15, and 8, respectively) undergoing endoscopic sinus surgery was performed. Validated patient reported symptom scores and objective endoscopic scores were collected preoperatively and 12 months postoperatively. Mucosal tissue samples were collected and examined for the presence of ICSA using immunohistochemical analysis. Tissue also underwent routine hematoxylin and eosin and Sirius Red staining to evaluate the inflammatory cell load and extent of fibrosis.
RESULTS: ICSA appeared to localize to the perinuclear region of the pseudostratified columnar respiratory epithelium. ICSA was more prevalent in CRS without nasal polyps (CRSsNP) than in CRS with nasal polyps (CRSwNP) or controls (80% vs 56% vs 38%, respectively). ICSA positive status did not appear to influence symptom or endoscopic scores at the time of surgery nor 12 months postoperatively. Lymphocytes and total inflammatory cells were significantly increased in ICSA(+) group than ICSA(-) groups (36.4 vs 22.4 cells/area and 53.8 vs 29.1 cells/area, respectively). There was no difference found in fibrosis.
CONCLUSION: This study indicated that ICSA was most prevalent in CRSsNP patients and was associated with increased lymphocytia and total inflammatory cells but not with worse symptomatology, endoscopy results, or basement membrane (BM) thickening.
© 2016 ARS-AAOA, LLC.

Entities:  

Keywords:  FESS; bacteriology; chronic rhinosinusitis; disease severity; postoperative

Mesh:

Year:  2016        PMID: 27080195     DOI: 10.1002/alr.21758

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  9 in total

1.  Risk Factors of Recurrent Infection in Patients with Staphylococcus aureus Bacteremia: a Competing Risk Analysis.

Authors:  Seongman Bae; Eun Sil Kim; Hee Seung Kim; Eunmi Yang; Hyemin Chung; Yun Woo Lee; Jiwon Jung; Min Jae Kim; Yong Pil Chong; Sung-Han Kim; Sang-Ho Choi; Sang-Oh Lee; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2022-06-28       Impact factor: 5.938

2.  Corynebacterium accolens inhibits Staphylococcus aureus induced mucosal barrier disruption.

Authors:  Shuman Huang; Karen Hon; Catherine Bennett; Hua Hu; Martha Menberu; Peter-John Wormald; Yulin Zhao; Sarah Vreugde; Sha Liu
Journal:  Front Microbiol       Date:  2022-09-14       Impact factor: 6.064

Review 3.  Unraveling the role of the microbiome in chronic rhinosinusitis.

Authors:  Alkis J Psaltis; Brett Wagner Mackenzie; Emily K Cope; Vijay R Ramakrishnan
Journal:  J Allergy Clin Immunol       Date:  2022-03-14       Impact factor: 14.290

4.  Mupirocin in the Treatment of Staphylococcal Infections in Chronic Rhinosinusitis: A Meta-Analysis.

Authors:  Jong Seung Kim; Sam Hyun Kwon
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

5.  Reduced Innate Immune Response to a Staphylococcus aureus Small Colony Variant Compared to Its Wild-Type Parent Strain.

Authors:  Judy J J Ou; Amanda J Drilling; Clare Cooksley; Ahmed Bassiouni; Stephen P Kidd; Alkis J Psaltis; Peter J Wormald; Sarah Vreugde
Journal:  Front Cell Infect Microbiol       Date:  2016-12-26       Impact factor: 5.293

6.  Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells.

Authors:  Frédéric Peyrusson; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

7.  Sub-Inhibitory Clindamycin and Azithromycin reduce S. aureus Exoprotein Induced Toxicity, Inflammation, Barrier Disruption and Invasion.

Authors:  Hua Hu; Mahnaz Ramezanpour; Andrew J Hayes; Sha Liu; Alkis J Psaltis; Peter-John Wormald; Sarah Vreugde
Journal:  J Clin Med       Date:  2019-10-04       Impact factor: 4.241

Review 8.  Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections.

Authors:  Adèle Sakr; Fabienne Brégeon; Jean-Louis Mège; Jean-Marc Rolain; Olivier Blin
Journal:  Front Microbiol       Date:  2018-10-08       Impact factor: 5.640

Review 9.  Staphylococcal trafficking and infection-from 'nose to gut' and back.

Authors:  Elisa J M Raineri; Dania Altulea; Jan Maarten van Dijl
Journal:  FEMS Microbiol Rev       Date:  2022-01-18       Impact factor: 16.408

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.